Clinical trials: Single Embryo Transfer
- Condition Single Embryo Transfer
- Funder type Industry (pharma, biotech, devices)
- Accepts healthy volunteers yes
Embryo Transfer
Study to Evaluate the Pharmacokinetics, Safety and Tolerability of GSK557296 in Healthy Women Volunteers After Single and Repeat Dosing
GSK557296 is being studied in women for the indication of enhanced embryo and or blastocyst implantation in women undergoing IVF treatment. This study will be the first dosing experience with this compound in women.
- Trial name
- NCT01669083
- Testing
- GSK557296 10 mg, GSK557296 150 mg, GSK557296 dose 3
- Where
- United States
- Volunteers
- 36 people, healthy volunteers welcome
- Sponsor
- GlaxoSmithKline